Features that are typically referenced as prognostic in primary TNBC38,40, including T cell / cancer cell ratio, PD-L1+ APCs, PD-1+ CD8+ T cells and T cells close to tumor cell, did not predict subsequent response to ICI when assessed in the primary tumor samples and ranked surprisingly low (below 1000). This evidence concerns the gene CD8A and neoplasm.